Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **enolase 2 pseudogene** is a nonfunctional genomic DNA sequence that closely resembles the enolase 2 (ENO2) gene but lacks the ability to produce a functional enzyme due to disabling mutations. Pseudogenes may arise through gene duplication or reverse transcription followed by integration into the genome[1][2][4]. While most pseudogenes, including this one, are considered "junk DNA," some may play regulatory roles at the RNA level, but no functional role or disease association has been specifically described for the enolase 2 pseudogene to date[1][2]. Pseudogenes can pose technical challenges during molecular genetic diagnostics due to their sequence similarity to functional genes, thus requiring careful assay design to avoid diagnostic errors[5]. Key Points: - This entry is not a functional drug target but a genomic pseudogene related to "enolase 2." - Pseudogenes are generally not categorized as receptors, enzymes, or therapeutic targets. - No interacting drugs, mechanisms of action, or biomarker uses are established for this pseudogene. - Classification: "Pseudogene," not a member of functionally active protein or receptor families.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enolase 2 pseudogene (ENSG00000218682).